PURPOSE OF REVIEW: Despite dramatic declines in acute rejection and early graft failure, long-term outcomes after kidney transplantation have improved little during the past 25 years. Most late allograft failure is attributed to chronic allograft nephropathy, but this is a clinicopathological description and not a diagnosis, and its pathogenesis and treatment are largely unknown. RECENT FINDINGS: Recent studies suggest that acute rejection during the first few months, and calcineurin inhibitor toxicity thereafter, may both contribute to chronic allograft nephropathy. There is also accumulating evidence that injury from antibody-mediated rejection may play an important pathogenic role in at least some patients with chronic allograft nephropathy, particularly those with transplant glomerulopathy. Therapeutic measures, including protocols to reduce calcineurin inhibitor exposure, remain largely unproven. SUMMARY: Understanding why so many kidney allografts fail, despite effective preventive measures for early acute rejection, is one of the most important areas of research in kidney transplantation today.
PURPOSE OF REVIEW: Despite dramatic declines in acute rejection and early graft failure, long-term outcomes after kidney transplantation have improved little during the past 25 years. Most late allograft failure is attributed to chronic allograft nephropathy, but this is a clinicopathological description and not a diagnosis, and its pathogenesis and treatment are largely unknown. RECENT FINDINGS: Recent studies suggest that acute rejection during the first few months, and calcineurin inhibitortoxicity thereafter, may both contribute to chronic allograft nephropathy. There is also accumulating evidence that injury from antibody-mediated rejection may play an important pathogenic role in at least some patients with chronic allograft nephropathy, particularly those with transplant glomerulopathy. Therapeutic measures, including protocols to reduce calcineurin inhibitor exposure, remain largely unproven. SUMMARY: Understanding why so many kidney allografts fail, despite effective preventive measures for early acute rejection, is one of the most important areas of research in kidney transplantation today.
Authors: Walter D Park; Matthew D Griffin; Lynn D Cornell; Fernando G Cosio; Mark D Stegall Journal: J Am Soc Nephrol Date: 2010-09-02 Impact factor: 10.121
Authors: Elisa J Gordon; Thomas R Prohaska; Mary P Gallant; Ashwini R Sehgal; David Strogatz; Recai Yucel; David Conti; Laura A Siminoff Journal: Transpl Int Date: 2009-07-10 Impact factor: 3.782
Authors: Marianne Niedermeier; Barbara Reich; Manuel Rodriguez Gomez; Andrea Denzel; Kathrin Schmidbauer; Nicole Göbel; Yvonne Talke; Frank Schweda; Matthias Mack Journal: Proc Natl Acad Sci U S A Date: 2009-10-06 Impact factor: 11.205
Authors: Niamh Kieran; Xiaotong Wang; James Perkins; Connie Davis; Elizabeth Kendrick; Ramaswamy Bakthavatsalam; Nancy Dunbar; Paul Warner; Karen Nelson; Kelly D Smith; Roberto F Nicosia; Charles E Alpers; Nicolae Leca; Jolanta Kowalewska Journal: J Am Soc Nephrol Date: 2009-09-03 Impact factor: 10.121
Authors: Raj Hanvesakul; Chandrashekhar Kubal; Jason Moore; Desley Neil; Mark Cook; Simon Ball; David Briggs; Paul Moss; Paul Cockwell Journal: PLoS One Date: 2011-08-31 Impact factor: 3.240